Bio B2B 〉 Selective Search Results
Your Selection Setting ：CRO；
Selective Search Results :
Biotech Companies 6 record(s)；
EirGenix is a Biologic Drug Development Company, and a Contract Development and Manufacturing Organization (CDMO). Current pipelines involve seven products in development ranging from discovery to clinical, such as HER2 family biosimilars, antibody-drug conjugates (ADCs), and carrier protein for vaccine therapy.EirGenix provides high quality and cost-effective service, supporting our clients
Protech Pharmaservices Corp.
Protech Pharmaservices Corporation (PPC) was founded in 1997 to meet the growing demands for R&D outsourcing from the Pharmaceutical and Biotech industries in the Asia- Pacific region. Working with its worldwide customers as a leading regional Contract Research Organization (CRO), PPC group provides professional services in “Clinical Research” (Phases I to IV) and “Contract Laboratories&rdquo
Vita Genomics, Inc.
The Leading Pharmacogenomics Company in Asia PacificVita Genomics, founded in March 2001, has established its headquarters and main facility in Taipei, Taiwan since January 2002. The mission of Vita Genomics is to study and understand what affects the Asian population in order to better diagnose, treat, and eventually cure diseases. Currently, in order to provide clinical and omics services to clinical
ScinoPharm Taiwan, Ltd.
Founded in 1997, with initial on-site operations beginning in November 1999, ScinoPharm offers a wide array of process R&D services and API manufacturing capabilities designed to satisfy customers' exact requirements and facilitate their rapid market introductions. ScinoPharm specializes in process R&D and the production of CGMP Active Pharmaceutical Ingredients (APIs).ScinoPharm targets
SCI Pharmtech, Inc.
SCI Pharmtech Inc., founded by Switzerland-based Siegfried Ltd. in 1987, is now a public company listed at Taiwan Stock Exchange.Since 1989, SCI has satisfied worldwide customers with quality and cost-effective APIs, advanced intermediates, and customproducts.Our fully equipped research laboratories, pilot and production plants and experienced staff ensure timely development and cost effectiveproduction
ACT Genomics is a global, science-driven biotech company enabling personalized treatment selection of cancer precision medicine with distinguished clinical cancer genomic profiling services.To make the world a better place, ACT Genomics' philanthropic philosophy was brought alive to rewrite cancer patients' difficult times by its cutting-edge Next Generation Sequencing (NGS) technology since